ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,869, issued on April 21, was assigned to Vanda Pharmaceutials Inc. (Washington).

"Methods for the administration of iloperidone" was invented by Curt Wolfgang (Germantown, Md.), Mihael Polymeropoulos (Potomac, Md.), Christian Lavedan (Potomac, Md.) and Simona Volpi (Derwood, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms."

The patent was filed on April 8, 2022, under Application No. 17/...